{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:07:09Z","timestamp":1761588429967,"version":"build-2065373602"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010607","name":"Universit\u00e0 degli Studi di Perugia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010607","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic sclerosis (SSc) and amyloidosis are rare, complex conditions that impair the function of multiple organs, each with distinct pathogenic mechanisms: autoimmunity for SSc and misfolded protein deposition for amyloidosis. We present the first documented case of a 57-year-old woman with coexisting SSc and systemic AL amyloidosis with multi-organ involvement, in which treatment for amyloidosis led to a notable improvement in SSc symptoms. The patient presented experiencing fatigue, exertional dyspnea, epigastric pain and syncopal episodes in the summer of 2023. Investigations revealed mild increase in left ventricle thickness, elevated NT-proBNP and troponin with negative coronary angiography. She was subsequently diagnosed with SSc with multi-organ involvement and systemic AL amyloidosis confirmed by biopsy. Treatment with a modified Dara-CyBorD protocol led to improvement in SSc symptoms, especially in terms of dyspnea and skin involvement. This is the first reported case of SSc coexisting with systemic AL amyloidosis. The patient responded well to therapy for amyloidosis, suggesting potential overlapping treatment benefits. A multidisciplinary approach was essential, and further studies are needed to explore therapeutic interactions between these two rare diseases.<\/jats:p>","DOI":"10.1007\/s00296-025-05982-5","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:25:57Z","timestamp":1758000357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Simultaneous onset of systemic sclerosis and light chain amyloidosis: the first report of a case report and review of the literature"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1934-4557","authenticated-orcid":false,"given":"Anna","family":"Colangelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2805-9313","authenticated-orcid":false,"given":"Francesco","family":"Tromby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Agliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2849-145X","authenticated-orcid":false,"given":"Lorenza","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1774-1916","authenticated-orcid":false,"given":"Giacomo","family":"Cafaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Crusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2924-1409","authenticated-orcid":false,"given":"Anna","family":"Mengoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3955-3879","authenticated-orcid":false,"given":"Cinzia","family":"Zuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-575X","authenticated-orcid":false,"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4776-2136","authenticated-orcid":false,"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4771-6981","authenticated-orcid":false,"given":"Carlo","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"5982_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12016-021-08889-8","volume":"64","author":"ME Truchetet","year":"2023","unstructured":"Truchetet ME, Brembilla NC, Chizzolini C (2023) Current concepts on the pathogenesis of systemic sclerosis. Clin Rev Allergy Immunol 64:262\u2013283. https:\/\/doi.org\/10.1007\/s12016-021-08889-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"5982_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9092687","volume":"9","author":"Y Asano","year":"2020","unstructured":"Asano Y (2020) The pathogenesis of systemic sclerosis: an understanding based on a common pathologic cascade across multiple organs and additional organ-specific pathologies. J Clin Med 9:1\u201327. https:\/\/doi.org\/10.3390\/jcm9092687","journal-title":"J Clin Med"},{"key":"5982_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00486-4","author":"R Al Hamed","year":"2021","unstructured":"Al Hamed R, Bazarbachi AH, Bazarbachi A et al (2021) Comprehensive review of AL amyloidosis: some practical recommendations. Blood Cancer J. https:\/\/doi.org\/10.1038\/s41408-021-00486-4. 11:","journal-title":"Blood Cancer J"},{"key":"5982_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13000-015-0407-9","volume":"10","author":"X Lin","year":"2015","unstructured":"Lin X, Mao Y, Qi Q et al (2015) Primary systemic amyloidosis initially presenting with digestive symptoms: a case report and review of the literature. Diagn Pathol 10:4\u20137. https:\/\/doi.org\/10.1186\/s13000-015-0407-9","journal-title":"Diagn Pathol"},{"key":"5982_CR5","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/european league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"5982_CR6","doi-asserted-by":"publisher","unstructured":"Gil KE, Truong V, Liu C et al (2024) Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation. Int J Cardiovasc Imaging 2559\u20132570. https:\/\/doi.org\/10.1007\/s10554-024-03262-0","DOI":"10.1007\/s10554-024-03262-0"},{"key":"5982_CR7","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/blood.2020008737","volume":"139","author":"G Palladini","year":"2022","unstructured":"Palladini G, Merlini G (2022) How I treat AL amyloidosis. Blood 139:2918\u20132930. https:\/\/doi.org\/10.1182\/blood.2020008737","journal-title":"Blood"},{"key":"5982_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3346\/jkms.2024.39.e225","volume":"39","author":"IC Benlidayi","year":"2024","unstructured":"Benlidayi IC, Gupta L (2024) CAse-BAsed review sTandards (CABARET): considerations for authors, reviewers, and editors. J Korean Med Sci 39:1\u20138. https:\/\/doi.org\/10.3346\/jkms.2024.39.e225","journal-title":"J Korean Med Sci"},{"key":"5982_CR9","doi-asserted-by":"publisher","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V (2022) Systemic sclerosis. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(22)01692-0","DOI":"10.1016\/S0140-6736(22)01692-0"},{"key":"5982_CR10","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1148\/rg.2021210006","volume":"41","author":"MD Sugi","year":"2021","unstructured":"Sugi MD, Kawashima A, Salomao MA et al (2021) Amyloidosis: multisystem spectrum of disease with pathologic correlation. Radiographics 41:1454\u20131474. https:\/\/doi.org\/10.1148\/rg.2021210006","journal-title":"Radiographics"},{"key":"5982_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","volume":"27","author":"MD Benson","year":"2020","unstructured":"Benson MD, Buxbaum JN, Eisenberg DS et al (2020) Amyloid nomenclature 2020: update and recommendations by the international society of amyloidosis (ISA) nomenclature committee. Amyloid 27:217\u2013222. https:\/\/doi.org\/10.1080\/13506129.2020.1835263","journal-title":"Amyloid"},{"key":"5982_CR12","unstructured":"Obata T, Takahashi H, Nosho K et al (1998) A case of systemic lupus erythematosus overlapping with progressive systemic sclerosis accompanied by deposition of AA amyloid in the stomach. Ryumachi Dec :810\u2013817"},{"key":"5982_CR13","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1136\/annrheumdis-2017-eular.1222","volume":"76","author":"M B\u00e9ly","year":"2017","unstructured":"B\u00e9ly M, Ap\u00e1thy \u0386 (2017) Characteristics of al-l light-chain and amyloid a deposition in progressive systemic sclerosis\u2014a comparative postmortem clinicopathologic study of 12 patients. Ann Rheum Dis 76:1283. https:\/\/doi.org\/10.1136\/annrheumdis-2017-eular.1222","journal-title":"Ann Rheum Dis"},{"key":"5982_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3349\/ymj.2006.47.5.737","volume":"47","author":"S Cho","year":"2006","unstructured":"Cho S, Bin, Park JS, Kim HO, Chung KY (2006) Scleroderma-like manifestation in a patient with primary systemic amyloidosis: response to high-dose intravenous Immunoglobulin and plasma exchange. Yonsei Med J 47:737\u2013740. https:\/\/doi.org\/10.3349\/ymj.2006.47.5.737","journal-title":"Yonsei Med J"},{"key":"5982_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1590\/abd1806-4841.20153320","volume":"90","author":"H Ma","year":"2015","unstructured":"Ma H, Chen M, Li J et al (2015) Syndrome in question. Bras Dermatol 90:270\u2013271. https:\/\/doi.org\/10.1590\/abd1806-4841.20153320","journal-title":"Bras Dermatol"},{"key":"5982_CR16","doi-asserted-by":"publisher","unstructured":"Romanowska-Pr\u00f3chnicka K, Dziewit M, Lesiak A et al (2024) Scleroderma and scleroderma-like syndromes. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1351675","DOI":"10.3389\/fimmu.2024.1351675"},{"key":"5982_CR17","doi-asserted-by":"publisher","unstructured":"Joy GM, Arbiv OA, Wong CK et al (2023) Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev 32. https:\/\/doi.org\/10.1183\/16000617.0210-2022","DOI":"10.1183\/16000617.0210-2022"},{"key":"5982_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/diagnostics12030669","volume":"12","author":"A Giuc\u0103","year":"2022","unstructured":"Giuc\u0103 A, Gegenava T, Mihai CM et al (2022) Sclerodermic cardiomyopathy\u2014a state-of-the-art review. Diagnostics 12:1\u201322","journal-title":"Diagnostics"},{"key":"5982_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.21037\/cdt-20-181","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Li J, Lin L et al (2020) Left and right ventricular myocardial deformation and late gadolinium enhancement: incremental prognostic value in amyloid light-chain amyloidosis. Cardiovasc Diagn Ther 10:470\u2013480. https:\/\/doi.org\/10.21037\/cdt-20-181","journal-title":"Cardiovasc Diagn Ther"},{"key":"5982_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10741-020-09998-w","volume":"27","author":"A Barison","year":"2022","unstructured":"Barison A, Aimo A, Todiere G et al (2022) Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction. Heart Fail Rev 27:191\u2013205. https:\/\/doi.org\/10.1007\/s10741-020-09998-w","journal-title":"Heart Fail Rev"},{"key":"5982_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13506129.2022.2093635","volume":"30","author":"AD Wechalekar","year":"2023","unstructured":"Wechalekar AD, Cibeira MT, Gibbs SD et al (2023) Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group. Amyloid 30:3\u201317. https:\/\/doi.org\/10.1080\/13506129.2022.2093635","journal-title":"Amyloid"},{"key":"5982_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ard-2024-226430","volume":"0","author":"F Del Galdo","year":"2024","unstructured":"Del Galdo F, Lescoat A, Conaghan PG et al (2024) EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis 0:1\u201312. https:\/\/doi.org\/10.1136\/ard-2024-226430","journal-title":"Ann Rheum Dis"},{"key":"5982_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/rheumatology\/kew488","volume":"56","author":"L-A Bissell","year":"2017","unstructured":"Bissell L-A, Anderson M, Burgess M et al (2017) Consensus best practice pathway of the UK systemic sclerosis study group: management of cardiac disease in systemic sclerosis. Rheumatol 56:312\u2013321. https:\/\/doi.org\/10.1093\/rheumatology\/kew488","journal-title":"Rheumatol"},{"key":"5982_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/rmdopen-2023-003604","volume":"9","author":"MT Holzer","year":"2023","unstructured":"Holzer MT, Ruffer N, Huber TB et al (2023) Daratumumab for autoimmune diseases: a systematic review. RMD Open 9:1\u20138. https:\/\/doi.org\/10.1136\/rmdopen-2023-003604","journal-title":"RMD Open"},{"key":"5982_CR25","doi-asserted-by":"publisher","unstructured":"Benfaremo D, Gabrielli A (2020) Is there a future for anti-cd38 antibody therapy in systemic autoimmune diseases? Cells 9. https:\/\/doi.org\/10.3390\/cells9010077","DOI":"10.3390\/cells9010077"},{"key":"5982_CR26","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.autrev.2023.103289","volume":"22","author":"X Ye","year":"2023","unstructured":"Ye X, Zhao Y, Ma W et al (2023) The potential of CD38 protein as a target for autoimmune diseases. Autoimmun Rev 22:2022\u20132023. https:\/\/doi.org\/10.1016\/j.autrev.2023.103289","journal-title":"Autoimmun Rev"},{"key":"5982_CR27","doi-asserted-by":"publisher","unstructured":"Szlasa W, Czarny J, Sauer N et al (2022) Targeting CD38 in neoplasms and Non-Cancer diseases. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14174169","DOI":"10.3390\/cancers14174169"},{"key":"5982_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01187","volume":"10","author":"KA Hogan","year":"2019","unstructured":"Hogan KA, Chini CCS, Chini EN (2019) The Multi-faceted Ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases. Front Immunol 10:1\u201312. https:\/\/doi.org\/10.3389\/fimmu.2019.01187","journal-title":"Front Immunol"},{"key":"5982_CR29","doi-asserted-by":"publisher","first-page":"101902","DOI":"10.1016\/j.isci.2020.101902","volume":"24","author":"B Shi","year":"2021","unstructured":"Shi B, Wang W, Korman B et al (2021) Targeting CD38-dependent NAD\u2009+\u2009metabolism to mitigate multiple organ fibrosis. iScience 24:101902. https:\/\/doi.org\/10.1016\/j.isci.2020.101902","journal-title":"iScience"},{"key":"5982_CR30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/BOR.0000000000000737","volume":"32","author":"TR Peclat","year":"2020","unstructured":"Peclat TR, Shi B, Varga J, Chini EN (2020) The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis. Curr Opin Rheumatol 32:488\u2013496. https:\/\/doi.org\/10.1097\/BOR.0000000000000737","journal-title":"Curr Opin Rheumatol"},{"key":"5982_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.1072462","volume":"13","author":"S Agarbati","year":"2022","unstructured":"Agarbati S, Benfaremo D, Viola N et al (2022) Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis. Front Immunol 13:1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2022.1072462","journal-title":"Front Immunol"},{"key":"5982_CR32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/rheumatology\/key151","volume":"58","author":"D Khanna","year":"2019","unstructured":"Khanna D, Tashkin DP, Denton CP et al (2019) Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung disease. Rheumatol (United Kingdom) 58:567\u2013579. https:\/\/doi.org\/10.1093\/rheumatology\/key151","journal-title":"Rheumatol (United Kingdom)"},{"key":"5982_CR33","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ajh.25819","volume":"95","author":"MA Gertz","year":"2020","unstructured":"Gertz MA (2020) Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment. Am J Hematol 95:848\u2013860. https:\/\/doi.org\/10.1002\/ajh.25819","journal-title":"Am J Hematol"},{"key":"5982_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","volume":"19","author":"JE Pope","year":"2023","unstructured":"Pope JE, Denton CP, Johnson SR et al (2023) State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol 19:212\u2013226. https:\/\/doi.org\/10.1038\/s41584-023-00909-5","journal-title":"Nat Rev Rheumatol"},{"key":"5982_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/dermatopathology8030028","volume":"8","author":"L Atzori","year":"2021","unstructured":"Atzori L, Ferreli C, Matucci-Cerinic C et al (2021) Primary localized cutaneous nodular amyloidosis and limited cutaneous systemic sclerosis: additional cases with dermatoscopic and histopathological correlation of amyloid deposition. Dermatopathology 8:229\u2013235. https:\/\/doi.org\/10.3390\/dermatopathology8030028","journal-title":"Dermatopathology"},{"key":"5982_CR36","doi-asserted-by":"crossref","unstructured":"Marano AL, Selim MA, Cardones AR, Burton CS (2018) Nodular amyloidosis in a patient with systemic scleroderma. Dermatol Online J 24","DOI":"10.5070\/D3249041415"},{"key":"5982_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-4362.1994.tb02928.x","volume":"33","author":"M Chanoki","year":"1994","unstructured":"Chanoki M, Ishii M, Hamada T (1994) Progressive systemic scleroris associated with cutaneous amyloidosis. Int J Dermatol 33:648\u2013649","journal-title":"Int J Dermatol"},{"key":"5982_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/jmedsci.jmedsci_64_16","volume":"37","author":"YH Chiu","year":"2017","unstructured":"Chiu YH, Chen PJ, Chang YM, Hou TY (2017) Gastrointestinal amyloidosis in a patient with systemic sclerosis. J Med Sci 37:117\u2013119. https:\/\/doi.org\/10.4103\/jmedsci.jmedsci_64_16","journal-title":"J Med Sci"},{"key":"5982_CR39","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/milmed\/134.12.1430","volume":"134","author":"WC Lowe","year":"1969","unstructured":"Lowe WC (1969) Scleroderma and amyloidosis. Mil Med 134:1430\u20131433. https:\/\/doi.org\/10.1093\/milmed\/134.12.1430","journal-title":"Mil Med"},{"key":"5982_CR40","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/art.1780250919","volume":"25","author":"HM Horwitz","year":"1982","unstructured":"Horwitz HM, Dibeneditto JD, Allegra SR, Baumann HM (1982) Scleroderma, amyloidosis, and extensor tendon rupture. Arthritis Rheum 25:1141\u20131143. https:\/\/doi.org\/10.1002\/art.1780250919","journal-title":"Arthritis Rheum"},{"key":"5982_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2133.1995.tb08654.x","volume":"132","author":"A Az\u00f2n-Masoliver","year":"1995","unstructured":"Az\u00f2n-Masoliver A (1995) Widespread primary localized cutaneous amyloidosis (macular form) associated with systemic sclerosis. Br J Dermatol 132:163\u2013165","journal-title":"Br J Dermatol"},{"key":"5982_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s100670170048","volume":"20","author":"GE Pamuk","year":"2001","unstructured":"Pamuk GE, Pamuk ON, Altiparmak MR et al (2001) Secondary amyloidosis in progressive systemic sclerosis. Clin Rheumatol 20:285\u2013287. https:\/\/doi.org\/10.1007\/s100670170048","journal-title":"Clin Rheumatol"},{"key":"5982_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-4632.2008.04058.x","volume":"49","author":"M Shiman","year":"2009","unstructured":"Shiman M, Ricotti C, Miteva M et al (2009) Primary localized cutaneous nodular amyloidosis associated with CREST (calcinosis, raynaud\u2019s phenomenon, esophageal motility disorders, sclerodactyly, and telangiectasia) syndrome. Intern J Dermatology 49:229\u2013230. https:\/\/doi.org\/10.1111\/j.1365-4632.2008.04058.x","journal-title":"Intern J Dermatology"},{"key":"5982_CR44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2340\/00015555-0855","volume":"90","author":"N Kikuchi","year":"2010","unstructured":"Kikuchi N, Sakai E, Nishibu A et al (2010) Primary localized cutaneous amyloidosis in patients with scleroderma. Acta Derm Venereol 90:326\u2013327. https:\/\/doi.org\/10.2340\/00015555-0855","journal-title":"Acta Derm Venereol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05982-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05982-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05982-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:02:30Z","timestamp":1761588150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05982-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["5982"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05982-5","relation":{},"ISSN":["1437-160X"],"issn-type":[{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. All authors contributed to the conception and design of the study. All authors take full responsibility for the integrity and accuracy of all aspects of the work. All authors read and approved the final manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}},{"value":"Patient signed informed consent regarding publishing her data and photographs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No related congress abstract has been published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Congress abstract"}}],"article-number":"227"}}